The Medicines and Medical Devices Bill was debated in the House of Lords on the first day of the Committee stage.
The Bill seeks to address the regulatory gap after Brexit to introduce regulation-making and delegate powers covering the fields of human medicines, clinical trials of human medicines, veterinary medicines and medical devices. Its purpose is to enable the existing regulatory frameworks to be updated at the end of the Transition Period.
- The possibility of a sunset provision which would give the Bill an expiry date to enable Parliament to debate the Bill again in the future
- The introduction of an amendment to ensure regulations can only be made if they promote the health and safety of the public
- Alignment with the EU regarding medicines and medical devices
- The power of the Bill to create criminal offences through secondary legislation, and
- The degree of parliamentary scrutiny for the Bill’s provisions.
The Committee will return to continue debating the Bill and MAP will track its progress.
For more information, please see the debate transcript.